MSB 2.51% 97.0¢ mesoblast limited

Ann: MSB Annual Financial Results and Operational Progress, page-45

  1. 12,446 Posts.
    lightbulb Created with Sketch. 3374
    All rational - but, it still a shitty day and made worst by these grave dancers mad.png
    None of my questions regarding the P3 trial has been addressed, as we are still waiting on OTAT and the potency assays.

    Why this additional potency assays requirement?Which was not required previously in the 300 patient trial?
    With the urgency of the pandemic - I would expect some concurrent activities mad.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.